MintNeuro raises $5M to build chips for brain-computer interfaces
What's the deal? UK-based semiconductor company MintNeuro has raised $5 million in an early-stage round to scale its chip platform for neural devices, from implants to wearables. Odyssey VenturesDealroom has a profile for this one. Try Dealroom → led, with participation from 33EastDealroom has a profile for this one. Try Dealroom →, JSK InvestmentsDealroom has a profile for this one. Try Dealroom →, and Alumni Ventures, plus returning backers Empirical VenturesDealroom has a profile for this one. Try Dealroom → and Jumpspace VenturesDealroom has a profile for this one. Try Dealroom →.
What's the endgame? MintNeuro builds a modular chip platform purpose-built for neural sensing, signal processing, and stimulation — listening to nerve signals, interpreting them, and delivering precise electrical pulses. It wants developers to build on its chips rather than adapt generic components or fund years of custom design.
Why now? Neural devices are opening new approaches to conditions from Parkinson's and epilepsy to depression and hearing loss. But the industry has lacked standard chips built for the extreme power, size, safety, and signal-quality demands of these devices.
What's the traction? MintNeuro has delivered working silicon and hit integration milestones with partners including Motif Neurotech and Amber Therapeutics. Earlier this year, it signed a multi-year commercial supply deal with Motif, backing a minimally invasive neurostimulator initially targeting treatment-resistant depression.
Where the money goes: MintNeuro will grow its engineering and commercial teams, bring products to market, and strengthen its US presence alongside its UK and European base. "This funding moves us from technology validation to commercial scale-up," said co-founder and chief executive officer Dorian Haci.
The signal: The round sits in roughly the 32nd percentile by size — modest for the sector, but pooling deep tech, medtech, and early-stage investors across Europe and the US. That mix reflects growing demand for the hardware needed to scale neurotechnology, a frontier where value may accrue to whoever solves the foundational infrastructure first.
Read more: prnewswire.com
Image credit: MintNeuro
